Document ID: FDA-2017-N-6644-0021
Agency: fda
Document Type: Notice
Title: Fiscal Year 2020 Generic Drug Regulatory Science Initiatives; Public
Workshop; Remote Only
Posted Date: 2020-04-30T04:00Z

[Federal Register Volume 85, Number 84 (Thursday, April 30, 2020)]
[Notices]
[Page 23968]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09168]

[[Page 23968]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-6644]

Fiscal Year 2020 Generic Drug Regulatory Science Initiatives; 
Public Workshop; Remote Only

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration is announcing that the 
following public workshop entitled ``FY 2020 Generic Drug Regulatory 
Science Initiatives'' announced in the Federal Register on March 10, 
2020, is being modified to take place remotely.

DATES: The public workshop will be held on May 4, 2020, from 8:30 a.m. 
to 4:30 p.m. Submit either electronic or written comments on this 
public workshop by June 4, 2020. See the SUPPLEMENTARY INFORMATION 
section for registration and participation information.

FOR FURTHER INFORMATION CONTACT: Stephanie Choi, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 75, Rm. 4732, Silver Spring, MD 20993-0002, 240-
402-7960, Stephanie.Choi@fda.hhs.gov; or Robert Lionberger, Center for 
Drug Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 75, Rm. 4722, Silver Spring, MD 20993, 240-402-
7957, Robert.Lionberger@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: Due to the ongoing COVID-19 pandemic, this 
workshop announced in the Federal Register on March 10, 2020 (85 FR 
13905) is being changed from in person to remote only. How to register 
and participate in this remote meeting will be communicated on the FDA 
web page at the following address: https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/fy-2020-generic-drug-regulatory-science-initiatives-public-workshop-05042020-05042020.

    Dated: April 24, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-09168 Filed 4-29-20; 8:45 am]
BILLING CODE 4164-01-P